Hadassah

Hadassah University Medical Center Hosts Bone Marrow Transplant Reunion

Sunday, Jan 15 2012

Two Israeli Arab children who received bone marrow transplants a year ago recently met with their Israeli Arab donors at a reunion hosted by the Hadassah University Medical Center.

The donors are 2 of 65 individuals who were found to be genetically matched to Arab patients in Israel and abroad, thanks to the Bone Marrow Registry created at Hadassah for Arab patients. Eleven of them have already donated their bone marrow and most of the transplantations proved successful.

Hadassah established the registry in October 2008 because 40 percent of Arab patients did not have potential donors and there was no registry for Arabs in the world. It has since been supported by Hadassah Austria and the Kahane Foundation in Austria.

Dr. Amal Bishara manages the registry, together with Prof. Chaim Brautbar, who founded the Hadassah Tissue Typing Unit, and Dr. Shoshana Israel, its current director. Over 15,000 Israeli Arabs joined the registry during more than 90 campaigns in Arab villages and cities in Israel. These campaigns included lectures in Arab colleges and public institutions, as well as ongoing advertisements in Israel's Arab media.

"This was a very moving occasion" said Dr. Bishara. "We are all grateful to the donors, who opened the possibility for new life for people they did not know at all."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.

READ MORE ›
alt_text

Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.

READ MORE ›
alt_text

Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More